Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#227 most reported symptom for this vaccine
Injection site nodule has been reported 50 times in association with Rotavirus (Rotateq) vaccination in VAERS. This represents 0.2% of all 25,020 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 3 involved hospitalization (6.0%).
Injection site nodule is the #227 most frequently reported symptom for Rotavirus (Rotateq) out of 1365 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 50 reports of Injection site nodule after Rotavirus (Rotateq) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.